Drug Allergy Market Size, Share, Development, Growth and Demand Forecast to 2023

marketresearchfuture

Drug Allergy is a standout amongst the most widely recognized sorts of hypersensitivities. It is the extreme touchiness of the safe framework to medication or drug. Any sorts of medications, for example, medicine, nonprescription or home grown can prompt Drug Allergy. Some basic manifestations of the medication sensitivities are hives, skin rash, tingling of the eyes or skin, swelling of the face, lips, or tongue, wheezing, and others. Treatment can ease and anticipate extreme responses.

Expanding mindfulness about different hypersensitivities, the presentation of the new treatment of items and rising interest from developing markets drives the development of the worldwide market. New research to forestall sedate hypersensitivities is another key driver for the market. The worldwide Drug Allergy Market is developing respectably and is required to proceed with its development over the figure time frame.

The global Drug Allergy Market is expected to grow at the CAGR of ~5.1% during the forecast period and is estimated to reach USD 4764.0 million by 2023.

Competitive Analysis:

Some of the key players in this market: AstraZeneca (UK), Bayer (US), Circassia (US), HAL Allergy Group (the Netherlands), Johnson & Johnson Services, Inc. (US), MAGNA Pharmaceuticals, Inc. (US), Stallergenes Greer (UK), and others.

Regional Analysis of the Global Drug Allergy Market:

The Americas dominate the global market for the drug allergy. The Americas mainly include North America and Latin America, out of which North America accounts for the majority of the market share of this region. The US is the top revenue generating market in North America and is one of the important markets for the global drug allergy treatment. Approximately 10% of the total US population have drug allergies. Latin America drug allergy market is also growing significantly and mainly includes Brazil, Argentina, and Chile. Europe is the second largest market in the globe owing to increasing cases of drug allergy.

Europe is mainly divided into Eastern Europe and Western Europe. More developed Western European countries like Germany, UK and France are dominating this market while East European region is also growing significantly. Increasing cases of drug allergies are one of the major factors for the growth of the Europe market.

Asia Pacific region is showing the fastest growth rate in the global drug allergy market due to some major factors such as increasing awareness about various drug allergies, availability of treatment products, and rapidly improving healthcare facilities. Japan is holding the major market share while China’s Drug Allergy Industry is expected to show the fastest growth in this region. Changing healthcare practices and increasing patient involvement play an important role in the growth of this market.

The Middle East & Africa is expected to experience a limited growth due to lack of awareness about diseases, traditional healthcare practices, etc. The Middle East region dominates the market due to some of the major factors, for instance, developed healthcare facilities and government support to improve public health.

Brief TOC

  1. Report Prologue
  2. Introduction
  3. Research Methodology
  4. Market Dynamics
  5. Market Factor Analysis
  6. Global Drug Allergy Market By Type
  7. Global Drug Allergy Market By Diagnosis
  8. Global Drug Allergy Market By Treatment
  9. Global Drug Allergy Market By End User
  10. Global Drug Allergy Market By Region
  11. Competitive Landscape
  12. Company Profile
  13. Conclusion
  14. Appendix

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

7 Key Projections on Expansion of Syringes Market through 2022

Going forward, a majority of medical procedures in the global healthcare industry will be performed through invasive techniques. The demand for syringes will continue to prevail in the years to come, urging syringe manufacturers remain optimistic. Pivotal importance of syringes as a product in the surgicals industries is expected to remain intact. Fact.MR projects that in 2017, more than US$ 11.3 Bn will be spend by patients, hospitals and other end-users for buying syringes.

In addition to this, rising demand for multifunctional syringes will also shape the dynamics of global syringes market in the future. By the end of 2022, the global market for syringes will have expanded at a robust CAGR of 7.8%, recording an estimated revenues of US$ 16.5 Bn. Following insights are excerpted from this report, which offers key projections on the growth of global syringes market during 2017-2022.

  1. Firstly, the report highlights that North America and the Asia-Pacific excluding Japan (APEJ) regions will be at the forefront of global syringes market expansion. The APEJ syringes market will witness highest growth, bringing in revenues over US$ 5.7 Bn by 2022-end.
  2. Active reforms in the healthcare infrastructure across the US and Canada are likely to remain profitable for syringes market. In 2017, more than US$ 2.5 Bn worth of syringes will be sold in North America, which will soar vigorously through the forecast period to reflect 8.5% CAGR.
  3. Japan, on the other hand, is expected to showcase a sluggish revenue growth for its syringes market, exhibiting a CAGR of 4.3%. The report also projects that Europe’s syringe sales will rise steadily, raking over US$ 4 Bn by the end of 2022.
  4. With increasing complexity in medical & surgical procedures, the demand for specialized syringes is expected to remain higher than that of general syringes. The report expects that a little less than 30% of the global syringes market value will be attained by the sales of specialized syringes. Nevertheless, this contribution will remain dominant compared to general syringes, the sales of which are likely to amass revenues over US$ 3.5 Bn by the end of forecast period.
  5. Over 80% of syringes sold in the global market over the forecast period will be disposable. With that said, the demand for reusable syringes will not be listless, as revenues from global sales of such syringes will reflect a steady growth at 6% CAGR.
  6. The report also highlights that over two-third volume of syringes expected to be sold in the world will be accounted by hospitals. While hospitals will be the largest end-users for syringes, the report also projects that 99.4% of the global syringes market revenues will be arising from sales of polymer syringes through 2022.

According to the report, the companies that are anticipated to remain active in the expansion of global syringes market through 2022 include Becton, Dickinson and Company, B. Braun Melsungen AG, Gerresheimer AG, Hindustan Syringes & Medical Devices Limited, Terumo Corporation, Nipro Corporation, Schott AG, Medtronic PLC, Smiths Group plc., and Codan Medizinische Geräte GmbH & Co Kg.

About Fact.MR       
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.

Tuberculosis Drugs Market to Reflect Impressive Growth Rate by 2025

Tuberculosis (TB) is an infectious disease, which is caused by Mycobacterium tuberculosis. These bacteria generally infect human lungs. However, it can infect other body parts/organs as well. Three major types of tuberculosis are found: latent, active, and drug-resistant tuberculosis. Symptoms are not identifiable in case of latent tuberculosis, due to presence of an inactive form of bacteria. In active tuberculosis, symptoms are clearly visible and they can spread from one person to another. Coughing for more than two weeks, chest pain, coughing up blood, chills, fatigue, unintentional weight loss, fever, and loss of appetite are some of the common symptoms of active tuberculosis. HIV/AIDS, severe kidney disease, cancer, diabetes, and malnutrition are some of the key risk factors generally found to be associated with tuberculosis.

Tuberculosis can be diagnosed with the help of tests including blood tests, imaging tests (such as chest X-ray or CT scan), and sputum tests. Tuberculosis can be treated with the first-line or second-line therapy. As per a report by World Health Organization (WHO), tuberculosis is one of the leading causes of deaths occurring worldwide. In 2015, approximately 9 million new cases of TB and 1.5 million deaths caused by TB occurred worldwide. Currently, WHO and certain government agencies are working toward reduction of tuberculosis burden globally, with the help of programs such as Stop TB. In December 2015, Multi-Drug Resistant Tuberculosis Program was also launched to check the tuberculosis prevalence across the globe.

Growing prevalence of multi-drug resistant tuberculosis is driving the tuberculosis drugs market. Drug shortages is a major restraint for the tuberculosis drugs market, especially in low- to medium-income countries of the world. Tuberculosis associated with diseases such as HIV/AIDS and conditions such as obesity is extremely difficult to manage. The tuberculosis drugs market can be segmented based on drug class, disease type, end-user, and region. In terms of drug class, the market can be categorized into first-line therapy, second-line therapy, and combination therapy. Isoniazid, Pyrazinamide, Rifampin, and Ethambutol majorly constitute the first-line therapy for TB; while Streptomycin, Capreomycin, Ethionamide, Levofloxacin, and Gatifloxacin are generally considered as a part of the second-line therapy. Second-line therapy is expected to be a rapidly growing segment of the tuberculosis drugs market.

Based on disease type, the tuberculosis drugs market can be segmented into latent tuberculosis, active tuberculosis, and drug-resistant tuberculosis. The drug-resistant tuberculosis segment is expected to expand rapidly during the forecast period. In terms of distribution channel, the market can be divided into hospital pharmacy, retail pharmacy, and others. The hospital pharmacy segment held the leading share in the global tuberculosis drugs market in 2016. The segment is projected to expand at a significant CAGR during the forecast period. The others segment is expected to gain a significant market share during the forecast period, due to launch of national government programs.

In terms of geography, the global tuberculosis drugs market can be categorized into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific dominated the global tuberculosis drugs market in 2016. Key factors responsible for growth of the market in Asia Pacific are presence of large patient population and high incidence rate of TB, especially in some of the developing economies of the region such as India and China. On the other hand, North America and Europe have a relatively small-sized patient pool with lower incidence rate of the disease. However, high awareness, well-developed health care infrastructure, rapid adoption of advanced yet expensive TB tests, and high purchasing power are driving the market in these regions.

Key players operating in the global tuberculosis drugs market are Sanofi, Novartis AG, Bayer AG, Lupin Limited, Zydus Cadila, Merck & Co., Inc., Pfizer Inc., and AstraZeneca.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Shreyas is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Telemedicine Carts & Systems Market – Global Indutry Insights and Forecast till 2022

worldwidemarketreports

Telemedicine Carts & Systems Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).

The report firstly introduced the Telemedicine Carts & Systems basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The report includes six parts, dealing with:
1.) basic information;
2.) the Asia Telemedicine Carts & Systems Market;
3.) the North American Telemedicine Carts & Systems Market;
4.) the European Telemedicine Carts & Systems Market;
5.) market entry and investment feasibility;
6.) the report conclusion.

Table of Contents

Part I Telemedicine Carts & Systems Industry Overview

Chapter One Telemedicine Carts & Systems Industry Overview
1.1 Telemedicine Carts & Systems Definition
1.2 Telemedicine Carts & Systems Classification Analysis
1.2.1 Telemedicine Carts & Systems Main Classification Analysis
1.2.2 Telemedicine Carts & Systems Main Classification Share Analysis
1.3 Telemedicine Carts & Systems Application Analysis
1.3.1 Telemedicine Carts & Systems Main Application Analysis
1.3.2 Telemedicine Carts & Systems Main Application Share Analysis
1.4 Telemedicine Carts & Systems Industry Chain Structure Analysis
1.5 Telemedicine Carts & Systems Industry Development Overview
1.5.1 Telemedicine Carts & Systems Product History Development Overview
1.5.1 Telemedicine Carts & Systems Product Market Development Overview
1.6 Telemedicine Carts & Systems Global Market Comparison Analysis
1.6.1 Telemedicine Carts & Systems Global Import Market Analysis
1.6.2 Telemedicine Carts & Systems Global Export Market Analysis
1.6.3 Telemedicine Carts & Systems Global Main Region Market Analysis
1.6.4 Telemedicine Carts & Systems Global Market Comparison Analysis
1.6.5 Telemedicine Carts & Systems Global Market Development Trend Analysis

About WMR :

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

1001 4th Ave,

#3200

Seattle, WA 98154,

U.S

Tel: +1 415 871 0703

Email: sales@worldwidemarketreports.com

Pranali is a BCA in computer science by education and a technology enthusiast by passion. She has a stint of experience in Blogging and SEO and loves to write.

Concentrating Solar Power Market To Gain From Increasing Awareness About Renewable Energy Along With Government Regulations To Control Growing Carbon Footprint Till 2025

grandviewresearch

The global concentrated solar power market is predicted to reach USD 8.92 billion by 2025, according to a new report by Grand View Research, Inc. Increasing awareness about renewable energy along with government regulations to control growing carbon footprint is further propelling the market growth.

Increasing clean energy adoption over non-renewable fuels is expected to drive the global concentrated solar power over the forecast timeframe. Favourable government regulations towards reduction of carbon footprint and greenhouse gas (GHG) emissions will further enhance the business growth.

Growing electricity demand along with rising investments to augment the efficiency index will provide an impetus to the concentrated solar power market growth. The Federal Government sponsored USD 9 million towards the research and development of six new CSP projects in the country, to reduce the total project costs though technological growth.

Substantial reduction in the component costs along with supportive government incentives like energy certificates, and carbon credits will expand the concentrated solar power market over the forecast period. Regulators around the world have been encouraging grid integration, making it an affordable alternative compared to non-renewable energy sources.

Concentrating Solar Power technology can store solar energy in the form of heat, even post sunset, which is perceived as the greatest advantage that it offers over all the other competing technologies. Reliable power supply coupled with flexibility in usage assist in bridging the demand supply deficit, currently faced by nations especially in the developing world. However, CSP technology is capital intensive as compared to other solar thermal technologies, as this may prove to be a restraint for the its adoption over the forecast period.

In terms of technology, the parabolic trough technology held over 75% of the global concentrated solar power market share in 2016. Matured technology coupled with affordable costs as compared to other forms of available systems will positively influence the growth of the concentrating solar power market over the forecast period. Power tower technology was valued over USD 955.5 million by 2025. Enhanced heat storage ability, higher efficiency, and favourable capacity factor will augment the business growth.

Further key findings from the report suggest

  • The U.S. concentrated solar power market, in terms of value, will witness growth of over 18.9% over the forecast period. Favourable government initiatives like tax credits, installation cost subsidies among other benefits will augment the business growth.
  • In Morocco, climatic conditions are favourable to the growth of CSP technology adoption, in tandem with the existing pipeline projects. Morocco concentrating solar power market is expected to exceed USD 852.2 million over the forecast period.
  • Spain concentrated solar power market size is set to exceed USD 1.22 billion by 2025. Spain is the market leader with the maximum installed capacity in the world as of year 2017.

Grand View Research has segmented the global CSP market on the basis of product and region:

Technology Outlook (Volume, Megawatts, 2014 – 2025) (Revenue, USD Million, 2014 – 2025)

  • Parabolic Trough
  • Linear Fresnel
  • Dish
  • Power Tower

Application Type Outlook (Volume, Megawatts, 2014 – 2025) (Revenue, USD Million, 2014 – 2025)

  • Utilities
  • Enhanced Oil Recovery
  • Desalination
  • Others

Regional Outlook (Volume, Megawatts, 2014 – 2025) (Revenue, USD Million, 2014 – 2025)

  • North America
    • S.
  • Europe
    • Spain
    • Italy
  • Asia Pacific
    • China
    • India
  • Central & South America
    • Morocco
    • Algeria
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Dhanashree is a Computer Engineer by education and a technology enthusiast by passion. She has a stint of experience in Blogging and SEO and loves to write.

5 Key Forecasts on Growth of Bone Growth Stimulator Market through 2022

Bone Growth Stimulator

As patients of spinal cord fractures continue to struggle with long duration consumed for complete recovery, surgeons and doctors continue to promote the use of bone growth stimulators. The Fact.MR forecast report on global bone growth stimulator market anticipates that global sales of these devices will bring in more than US$ 1.4 Bn by the end of 2017. Spinal fracture patients opting for bone growth stimulators is expected to rise due to increasing advancements in lowering patient discomfort. By the end of 2022, sales of bone growth stimulators in the global market is pegged to bring in US$ 1.91 Bn, exhibiting a steady growth at 5.3% CAGR.

Key Forecast Highlights

  1. According to the report, bone growth stimulation devices will account for nearly 56% share on global bone growth stimulator revenues in 2017. Platelet-rich plasmas, on the other hand, will be observed as promising product segment, revenues from which are expected to showcase robust growth at 6.2% CAGR. By the end of 2022, a little over US$ 450 Mn worth of platelet-rich plasmas will be sold in the global market for bone growth stimulators.
  2. In the view of poor road infrastructure and inferior healthcare facilities existing in the Asia-Pacific excluding Japan (APEJ) region, the demand for bone growth stimulators is expected to gain grounds. These factors are boosting the incidence of spinal fractures in this region, compelling doctors towards adoption of bone growth simulation therapy. Moreover, manufacturers of bone growth stimulators are expected to benefit from low wage costs and high resource availability by setting up their manufacturing units across APEJ region. By the end of 2022, over US$ 225 Mn worth of bone growth stimulators will be sold across the APEJ market.
  3. North America is expected to remain the largest market for bone growth stimulator. The report predicts that high healthcare spending implemented in Canada and the US will urge manufacturers towards developing advanced bone growth stimulators. Meanwhile, revenues amassed from sales of bone growth stimulators in Europe will contribute US$ 600 Mn in revenues by the end of 2022. Towards the end of forecast period, North America’s bone growth stimulator market is likely to soar at a CAGR of 6.2%.
  4. Application of bone growth stimulators in delayed union & non-union bone fracture treatments is expected to gain traction, reflecting a revenue growth at 5.7% CAGR. Spinal fusion surgeries will account for nearly 25% of the global bone growth stimulator sales in 2017, while their application in oral and maxillofacial surgeries will procure around US$ 250 Mn in global revenues.
  5. Hospitals and clinics are expected to remain largest end-users of bone growth stimulator throughout the forecast period. With more than 43% share, over US$ 800 Mn worth of bone growth stimulators will be sold in hospitals & clinics across the globe by 2022-end. Home care end-use of bone growth stimulator, on the other hand, is expected to create an incremental opportunity of more than US$ 100 Mn by 2022 over 2017.

The report has also profiled leading players in the global bone growth stimulator market, which include companies such as Orthofix International N.V., Medtronic plc, Zimmer Biomet Holdings, Inc., Bioventus Inc., Stryker Corporation, Johnson & Johnson, Arthrex, Inc., DJO Global Inc., Elizur Corporation, and Ossatec Benelux B.V.

Check Discount- https://www.factmr.com/connectus/sample?flag=D&rep_id=54

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.

Augmented Reality And Virtual Reality In Healthcare Market Is Expected To Reach USD 5.1 Billion By 2025: Grand View Research, Inc.

grandviewresearch

The global augmented reality & virtual reality in healthcare market is expected to reach USD 5.1 billion by 2025 according to a new report by Grand View Research, Inc. The growing adoption of Augmented Reality (AR) & Virtual Reality (VR) in medical field, increasing investments in such emerging technologies, and constant developments in healthcare IT are some of the key factors responsible for growth of this market.

The market is majorly driven by applications in surgical simulations, diagnostic imaging, patient care management, rehabilitation, and health management. The application of AR & VR in training medical professionals provides them enhanced understanding of anatomy & physiology and assists in complicated surgeries that require precision, thus, resulting in reduced complications and lesser trauma. VR helps patients get over their worst fears and phobias through the exposure therapy. These technologies are also gaining significance in fitness management due to the development of various health apps that help train doctors as well as patients.

The use of these advanced technologies in live streaming of surgeries for medical education coupled with patient monitoring & pain management serves as a market opportunity and is predicted to drive the segment substantially. These new disruptive technologies have revolutionized medical field and provide an innovative approach for transforming healthcare experience. The increasing focus on streamlining medical operations along with demand for better delivery of care services are driving the growing adoption of these technologies.

Increase in number of startups has led to higher demand for investments to fund development of AR & VR technologies. The market is witnessing an increase in private investments by various investors, which is expected to boost growth further. For instance, Swiss-based startup MindMaze is a well-funded company that has raised USD 100 million from Hinduja Group for development of VR hardware & software. In addition, increased government funding and supportive initiatives are expected to drive growth.

Further key findings from the report suggest:

  • The hardware segment held the majority of the revenue share in 2016 due to rise in adoption of wearable devices in healthcare
  • AR dominated the technology segment in 2016 owing to its increasing adoption in surgeries and medical training
  • North America dominated the global market for AR and VR due to greater adoption of advanced technology and sophisticated infrastructure
  • Asia Pacific AR and VR market is expected to witness a lucrative growth of 33% over the forecast period
  • Some of the key players include CAE HEALTHCARE; GE Healthcare; Intuitive Surgical; Hologic, Inc.; Virtual Realities, LLC; and Philips Healthcare

Grand View Research has segmented the augmented reality & virtual reality in healthcare market on the basis of component, technology and region:

Component Outlook (Revenue, USD Million, 2014 – 2025)

  • Hardware
  • Software
  • Service

Technology Outlook (Revenue, USD Million, 2014 – 2025)

  • Augmented Reality
    • Surgical Application
    • Rehabilitation
    • Training & Medical Education
  • Virtual Reality
    • Simulation
    • Diagnostics
    • Virtual Reality Exposure Therapy
    • Rehabilitation
    • Pain Distraction

Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Dhanashree is a Computer Engineer by education and a technology enthusiast by passion. She has a stint of experience in Blogging and SEO and loves to write.

Dental Practice Management Software Market Growth, Demand and Key Players to 2025

Dental Practice Management Software

Global Dental Practice Management Software Market: Snapshot

The global dental practice management software market is expected to display steadfast growth in the coming years mainly because of growing geriatric population globally and initiatives from several governments for oral health. As per statistics of the National Institute on Aging, in 2010, almost 524 million individuals, which is almost 8% of the global population were above the age of 65 years. By 2050, the number is expected to become 1.5 billion, which is almost 16% of the global population.

Advances in dentistry and advances in healthcare information technology along with rising awareness for oral health are also some pivotal factors driving the global dental practice management software market. In the U.S., for example, The Health Information Technology for Economic and Clinical Health Act fosters the adoption of health information technology.

Dental practice management software is all-important for modern dental practice. The set of powerful software connects the front desk with concerned departments and eliminates the need to store patient information on paper. The basic feature of practice management software is to store patient records, practice schedule, and all business information.

However, most software platforms offer much more capabilities that include management of clinical images, patient communications, and insurance claims. In addition, several dental practice management software enables clinicians to access key pieces of information remotely and allow patients to update and even submit information online.

The selection of dental practice management software for dental practices needs to satisfy initial and ongoing training requirement, reliable customer service, and timely upgrade of software.

Dental practice management software is an administrative tool that helps in operation of dental practices. The software is inclusive of all non-clinical operational functions such as appointment bookings, accounting, patient’s accounts, patient monitoring analytics, report generation, medical records, and bill generation. The software aids in maintaining high quality standard of patient care, is easy to use, saves time, and regularizes the data. Additional features can be added to enhance productivity such as anesthesia monitoring and use of radiographic systems.

The global dental practice management software market (DPMS) is projected to grow at a robust rate during the forecast period. Growing demand for dental services due to increase in geriatric population and rise in oral health care expenses are the key factors fueling the growth of the global dental practice management software market. Furthermore, technological advancements in the software, reduction of manpower, rise in investment by companies, integrated software with all features within a small package, higher penetration rates leading to increase in providers, and rise in demand for health care IT systems are the major factors augmenting the global market during the forecast period. However, high cost of software can restrain the dental practices management software market in few developing countries during the forecast period.

The global dental practice management software (DPMS) market can be segmented based on application, deployment mode, end-user, and region. In terms of application, the global market can be divided into appointment scheduling, patient communication, electronic claims, report generation, and others. The appointment scheduling segment is expected to dominate the global market due to increase in dental checkups as a result of rise in awareness about oral health. Based on deployment mode, the global dental practice management software market can be divided into web-based and cloud-based. The cloud-based segment is anticipated to grow at a robust rate during the forecast period. Factors such as availability of data at any point of time irrespective of place and no need of IT investments are propelling the segment. In terms of end-user, the global market can be segmented into corporate dental practices, individual dentists, and non-profit dental practices.

Geographically the dental practice management software market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the market, accounting for the largest share. High adoption rate of the software and increased oral health care expenditure propel the market in North America. Furthermore, technological advances in the software such as billing integrated with electronic health records have increased the penetration rate of the software in the region leading to market growth. Asia Pacific is anticipated to register faster growth rate during the forecast period. Asia Pacific is the most lucrative market due to increasing geriatric population, adoption of health care IT solutions for better standard of life, and rise in awareness towards oral health care.

Key players have adopted strategies such as mergers and acquisitions, cost effective and efficient products, and collaborative partnerships to sustain market position. Prominent players operating in the global dental practice management software market are ACE Dental, MOGO, Inc., Carestream Health, Patterson Companies, Inc., MacPractice, Inc., Henry Schein, Inc., Practice-Web, Datacon Dental Systems, and Dentisoft Technologies, among others.

Melanoma Cancer Diagnostics Market:8 Key Takeaways

Melanoma Cancer Diagnostics

According to a latest market research by fast-growing market research and consulting firm, the global melanoma cancer diagnostics market is poised to grow at over 7% CAGR and surpass US$ 853.5 million in revenues by 2022. Fact.MR’s report forecasts that North America and Europe will remain the most lucrative markets for melanoma cancer diagnostics market globally. Key takeaways from Fact.MR’s report are,

  • The U.S. melanoma cancer diagnostics market will grow at over 7% CAGR and reach US$ 409.2 Mn by 2022. By test type, BRAF mutation segment will continue to be the leading segment.
  • Germany is one of the largest markets for melanoma cancer diagnostics in Europe. Fact.MR projects the Germany melanoma cancer diagnostics market to grow at 7.4% CAGR through 2022. Hospital associated labs are the largest end-users of melanoma cancer diagnostics in Germany. The market in United Kingdom will grow at a higher rate than Germany, but it will be continue to be smaller in market size.
  • The market will be positive influenced by increasing R&D on cancer diagnosis and management. Increasing prevalence of melanoma and effective immunotherapies are expected to drive growth of the market globally.
  • Although the outlook on the global melanoma cancer diagnostics market is positive, limited funds in emerging countries, combined with challenges surrounding regulatory issues can stymie growth during the forecast period.
  • By test type, BRAF mutation segment will account for a significant share of global revenues. This test type will continue to be used widely in major markets of North America and Europe. The CTC segment, on the other hand, is projected to grow at a higher CAGR than BRAF segment. Immunohistochemistry, another test type, is projected to grow at over 6% CAGR in the global melanoma cancer diagnostics market.
  • The key end-use segments of the global melanoma cancer diagnostics market have been identified as hospital associated labs, cancer research institutes, and independent diagnostic laboratories. Among these, the hospital associated labs end-use segment is the most prominent globally. According to Fact.MR’s research, hospital associated labs will remain the largest end-users for melanoma cancer diagnostics market during the forecast period.
  • Demand is also expected to remain steady from independent diagnostic laboratories segment. In North America, demand from this segment is expected to surpass US$ 100 million by 2022. The trend will also remain strong in Europe, with this segment growing at nearly 8% CAGR during the forecast period.
  • Leading companies profiled in the report include Cancer Genetics, Inc., Myriad Genetics Inc. Abbott Laboratories, Foundation Medicine, Inc., and Pathway Genomics Corporation

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.

9 Key Takeaways from Fact.MR’s Report on Kidney Cancer Diagnostics Market

Kidney Cancer Diagnostics

Fact.MR, in its latest research, anticipates the global kidney cancer diagnostics market to witness an impressive expansion at a CAGR of 6.4% over the forecast period 2017 to 2022.

Tremendous transformations have been witnessed over the recent past, in the management and diagnosis of renal cell carcinoma (RCC), or, kidney cancer. Numerous discoveries, trails, and studies have been taken in active surveillance, renal biopsy, as well as minimally-invasive thermal ablation, on the back of surging diagnosis rate of the small renal masses, observed usually among individuals with high morbidity risks, undergoing operative treatment. These factors are expected to fuel growth of the global market for kidney cancer diagnostics.

Older population are most commonly affected by kidney cancer. Diagnosis of old-aged patients makes kidney cancer diagnostics an intricate chapter in the medical books. MRI and CT scan are staple diagnosis procedures in the global market for kidney cancer diagnostics, however, patients are anticipating the emergence of advanced and more effective diagnosis tests. Moreover, this urge to upgrade the diagnostic approach for kidney cancer patients is also resonated by medical organizations as they continue to direct heavy investments in research & developments of new diagnostic procedures. Improvements in early diagnosis tests have translated huge profits for market players, and these companies are also partnering with medical research organizations to develop diagnostic methods that can concurrently lower the maturation pace of tumor between multiples stages of kidney cancer.

9 Estimations from Fact.MR’s Report on the Global Kidney Cancer Diagnostics Market

  1. Based on end-users, the hospital-associated labs will remain preferred in the market for kidney cancer diagnostics, and are expected to account for the largest revenues over the forecast period.
  2. Independent diagnostic laboratories are estimated to remain the second largest end-users in the global market for kidney cancer diagnostics.
  3. Cancer research institutes will register the fastest expansion in the market during the forecast period.
  4. Immunochemistry tests will remain sought-after in the market for kidney cancer diagnostics, and revenues from these tests will account for US$ 351.8 Mn by 2022-end. Among test type, Immunochemistry test is expected to exhibit the highest CAGR through 2022, followed by the complete blood count test.
  5. Urine analysis is anticipated to remain the second most lucrative tests for diagnosis of kidney cancer across the globe.
  6. Revenues from blood chemistry tests related to kidney cancer diagnostics are expected to remain comparatively lower in the market over the forecast period.
  7. North America will continue to account for the largest revenues in the kidney cancer diagnostics market, followed by Europe.
  8. Market for kidney cancer diagnostics in Europe will register a relatively higher CAGR than in North America throughout the forecast period.
  9. Asia Pacific excluding Japan (APEJ) is expected to remain the fastest growing market for kidney cancer diagnostics over the forecast period.

Competition Tracking

The report has also profiled leading players in the global market for kidney cancer diagnostics, which include NeoGenomics Laboratories, Myriad Genetics Inc, NanoString Technologies Inc., Rosetta Genomics, Sysmex Corporation, Illumina, Inc., Roche Holding AG, Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., and Abbott Laboratories.

Check Discount- https://www.factmr.com/connectus/sample?flag=D&rep_id=56

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.